Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) average recommendation is hold with average Target Price of $7.94. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares closed at $6.96 on last trade day, by gaining 0.43%. Stock 52 week range is $4.05 – $9.25. Company’s market capitalization is $1.52 billion.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that it will present at the RBC Capital Markets Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s business on Wednesday, February 26, at 3:05 p.m. (ET). Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock advanced 1.62% and finished the last session at $8.79. The EPS of the stock remained -1.46. Company’s market capitalization is $1.63 billion.
MannKind Corporation (NASDAQ:MNKD) focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at upcoming conferences. The RBC Capital Markets 2014 Global Healthcare Conference on February 25, 2014 at 11:30 AM (ET) at The New York Palace in New York, New York. Cowen and Company 34th Annual Health Care Conference on March 3, 2014 at 3:30 PM (ET) at the Boston Marriott Copley in Boston, Massachusetts. MannKind Corporation (NASDAQ:MNKD) stock opened at $5.57 in last trading session and closed at $5.64. The 52 week range of the stock is $2.45 – $8.70 and the day range was $5.52 – $5.80.
The Rosen Law Firm announces that it is investigating potential securities fraud claims against Galena Biopharma Inc (NASDAQ:GALE) resulting from allegations that GALE may have paid outsiders to pump its stock using false and misleading articles while insiders dumped their shares. Galena Biopharma Inc (NASDAQ:GALE) stock opened at $3.47 in last trading session, and closed at $3.79, trading in the range of $3.26 – $3.93. The stock showed a negative weekly performance of -29.68%.
Leave a Reply